Influenza-like illness

Last updated

Influenza-like illness
WhoLab15.GIF
Proportion of positive influenza tests during a flu season.

Influenza-like illness (ILI), also known as flu-like syndrome or flu-like symptoms, is a medical diagnosis of possible influenza or other illness causing a set of common symptoms. These include fever, shivering, chills, malaise, dry cough, loss of appetite, body aches, nausea, and sneezing typically in connection with a sudden onset of illness. [1] In most cases, the symptoms are caused by cytokines released by immune system activation,[ citation needed ] and are thus relatively non-specific.

Contents

Common causes of ILI include the common cold and influenza, which tends to be less common but more severe than the common cold. Less common causes include side effects of many drugs and manifestations of many other diseases.[ citation needed ]

Definition

The term ILI can be used casually, but when used in the surveillance of influenza cases, can have a strict definition. The World Health Organization defines an illness as an ILI if the patient has a fever greater than or equal to 38 °C and a cough, which began in the last 10 days. If the patient requires hospitalisation, the illness is classified instead as a severe acute respiratory infection (SARI). [2] Other organisations may have different definitions. For instance, the CDC defines it as a 100 °F (38 °C) fever or greater, and a cough or sore throat. [3]

Causes

The causes of influenza-like illness range from benign self-limited illnesses such as gastroenteritis, rhinoviral disease, and influenza, to severe, sometimes life-threatening, diseases such as meningitis, sepsis, and leukemia.[ citation needed ]

Influenza

Technically, any clinical diagnosis of influenza is a diagnosis of ILI, not of influenza. This distinction usually is of no great concern because, regardless of cause, most cases of ILI are mild and self-limiting. Furthermore, except perhaps during the peak of a major outbreak of influenza, most cases of ILI are not due to influenza. [4] [5] ILI is very common: in the United States each adult can average 1–3 episodes per year and each child can average 3–6 episodes per year. [4]

Influenza in humans is subject to clinical surveillance by a global network of more than 110 National Influenza Centers. These centers receive samples obtained from patients diagnosed with ILI, and test the samples for the presence of an influenza virus. Not all patients diagnosed with ILI are tested, and not all test results are reported. Samples are selected for testing based on severity of ILI, and as part of routine sampling, and at participating surveillance clinics and laboratories. [6] The United States has a general surveillance program, a border surveillance program, and a hospital surveillance program, all devoted to finding new outbreaks of influenza.[ citation needed ]

In most years, in the majority of samples tested, the influenza virus is not present (see figure above). In the United States during the 2008–9 influenza season through 18 April, out of 183,839 samples tested and reported to the CDC, only 25,925 (14.1%) were positive for influenza. The percent positive reached a maximum of about 25%. [5] The percent positive increases with the incidence of infection, peaking with the peak incidence of influenza (see figure). During an epidemic, 60–70% of patients with a clear influenza-like illness actually have influenza. [7]

Samples are respiratory samples, usually collected by a physician, nurse, or assistant, and sent to a hospital laboratory for preliminary testing. There are several methods of collecting a respiratory sample, depending on requirements of the laboratory that will test the sample. A sample may be obtained from around the nose simply by wiping with a dry cotton swab. [8]

Other causes

Infectious diseases causing ILI include respiratory syncytial virus, malaria, acute HIV/AIDS infection, herpes, hepatitis C, Lyme disease, rabies, myocarditis, [9] Q fever, dengue fever, [10] poliomyelitis, pneumonia, measles, SARS, COVID-19, and many others.

Pharmaceutical drugs that may cause ILI include many biologics such as interferons and monoclonal antibodies. [11] [12] [13] Chemotherapeutic agents also commonly cause flu-like symptoms. Other drugs associated with a flu-like syndrome include bisphosphonates, caspofungin, and levamisole. [14] [15] A flu-like syndrome can also be caused by an influenza vaccine or other vaccines, and by opioid withdrawal in physically dependent individuals.[ citation needed ]

Diagnosis

Influenza-like illness is a nonspecific respiratory illness characterized by fever, fatigue, cough, and other symptoms that stop within a few days. Most cases of ILI are caused not by influenza but by other viruses (e.g., rhinoviruses, coronaviruses, human respiratory syncytial virus, adenoviruses, and human parainfluenza viruses). Less common causes of ILI include bacteria such as Legionella , Chlamydia pneumoniae , Mycoplasma pneumoniae , and Streptococcus pneumoniae . Influenza, RSV, and certain bacterial infections are particularly important causes of ILI because these infections can lead to serious complications requiring hospitalization. Physicians who examine persons with ILI can use a combination of epidemiologic and clinical data (information about recent other patients and the individual patient) and, if necessary, laboratory and radiographic tests to determine the cause of the ILI. [4] The use of multiplexed point-of-care testing such as CRP (C-reactive protein) along with an examination by a doctor may help to identify a bacterial and avoid an unnecessary antibiotic prescription. [16]

During the 2009 flu pandemic, many thousands of cases of ILI were reported in the media as suspected swine flu. Most were false alarms. A differential diagnosis of probable swine flu requires not only symptoms but also a high likelihood of swine flu due to the person's recent history. During the 2009 flu pandemic in the United States, the CDC advised physicians to "consider swine influenza infection in the differential diagnosis of patients with acute febrile respiratory illness who have either been in contact with persons with confirmed swine flu, or who were in one of the five U.S. states that have reported swine flu cases or in Mexico during the 7 days preceding their illness onset." [17] A diagnosis of confirmed swine flu required laboratory testing of a respiratory sample (a simple nose and throat swab). [17]

In rare cases

If a person with ILI also has either a history of exposure or an occupational or environmental risk of exposure to Bacillus anthracis (anthrax), then a differential diagnosis requires distinguishing between ILI and anthrax. [18] [19] [20] Other rare causes of ILI include leukemia and metal fume fever.

In horses

ILI occurs in some horses after intramuscular injection of vaccines. For these horses, light exercise speeds resolution of the ILI. Non-steroidal anti-inflammatory drugs (NSAIDs) may be given with the vaccine. [21]

See also

Related Research Articles

<i>Influenza A virus</i> Species of virus

Influenza A virus (IAV) is the only species of the genus Alphainfluenzavirus of the virus family Orthomyxoviridae. It is a pathogen with strains that infect birds and some mammals, as well as causing seasonal flu in humans. Mammals in which different strains of IAV circulate with sustained transmission are bats, pigs, horses and dogs; other mammals can occasionally become infected.

<span class="mw-page-title-main">Avian influenza</span> Influenza caused by viruses adapted to birds

Avian influenza, also known as avian flu or bird flu, is a disease caused by the influenza A virus, which primarily affects birds but can sometimes affect mammals including humans. Wild aquatic birds are the primary host of the influenza A virus, which is enzootic in many bird populations.

<span class="mw-page-title-main">Oseltamivir</span> Antiviral medication used against influenza

Oseltamivir, sold under the brand name Tamiflu among others, is an antiviral medication used to treat and prevent influenza A and influenza B, viruses that cause the flu. Many medical organizations recommend it in people who have complications or are at high risk of complications within 48 hours of first symptoms of infection. They recommend it to prevent infection in those at high risk, but not the general population. The Centers for Disease Control and Prevention (CDC) recommends that clinicians use their discretion to treat those at lower risk who present within 48 hours of first symptoms of infection. It is taken by mouth, either as a pill or liquid.

<span class="mw-page-title-main">Influenza A virus subtype H5N1</span> Subtype of influenza A virus

Influenza A virus subtype H5N1 (A/H5N1) is a subtype of the influenza A virus, which causes influenza (flu), predominantly in birds. It is enzootic in many bird populations, and also panzootic. A/H5N1 virus can also infect mammals that have been exposed to infected birds; in these cases, symptoms are frequently severe or fatal.

<span class="mw-page-title-main">Swine influenza</span> Infection caused by influenza viruses endemic to pigs

Swine influenza is an infection caused by any of several types of swine influenza viruses. Swine influenza virus (SIV) or swine-origin influenza virus (S-OIV) refers to any strain of the influenza family of viruses that is endemic in pigs. As of 2009, identified SIV strains include influenza C and the subtypes of influenza A known as H1N1, H1N2, H2N1, H3N1, H3N2, and H2N3.

Viral pneumonia is a pneumonia caused by a virus. Pneumonia is an infection that causes inflammation in one or both of the lungs. The pulmonary alveoli fill with fluid or pus making it difficult to breathe. Pneumonia can be caused by bacteria, viruses, fungi or parasites. Viruses are the most common cause of pneumonia in children, while in adults bacteria are a more common cause.

<span class="mw-page-title-main">Influenza A virus subtype H1N1</span> Subtype of Influenza A virus

Influenza A virus subtype H1N1 (A/H1N1) is a subtype of influenza A virus (IAV). Some human-adapted strains of H1N1 are endemic in humans and are one cause of seasonal influenza (flu). Other strains of H1N1 are endemic in pigs and in birds. Subtypes of IAV are defined by the combination of the antigenic H and N proteins in the viral envelope; for example, "H1N1" designates an IAV subtype that has a type-1 hemagglutinin (H) protein and a type-1 neuraminidase (N) protein.

<span class="mw-page-title-main">Influenza pandemic</span> Pandemic involving influenza

An influenza pandemic is an epidemic of an influenza virus that spreads across a large region and infects a large proportion of the population. There have been five major influenza pandemics in the last 140 years, with the 1918 flu pandemic being the most severe; this is estimated to have been responsible for the deaths of 50–100 million people. The 2009 swine flu pandemic resulted in under 300,000 deaths and is considered relatively mild. These pandemics occur irregularly.

<span class="mw-page-title-main">Canine influenza</span> Influenza occurring in canines

Canine influenza is influenza occurring in canine animals. Canine influenza is caused by varieties of influenzavirus A, such as equine influenza virus H3N8, which was discovered to cause disease in canines in 2004. Because of the lack of previous exposure to this virus, dogs have no natural immunity to it. Therefore, the disease is rapidly transmitted between individual dogs. Canine influenza may be endemic in some regional dog populations of the United States. It is a disease with a high morbidity but a low incidence of death.

<span class="mw-page-title-main">Childhood immunizations in the United States</span>

The schedule for childhood immunizations in the United States is published by the Centers for Disease Control and Prevention (CDC). The vaccination schedule is broken down by age: birth to six years of age, seven to eighteen, and adults nineteen and older. Childhood immunizations are key in preventing diseases with epidemic potential.

Adenovirus serotype 14 (Ad14) is a serovar of adenovirus which, unlike other adenovirus serovars, is known to cause potentially fatal adenovirus infections. According to the United States Centers for Disease Control and Prevention (CDC), as of September 2007, outbreaks have been identified in four states in the U.S., with ten identified deaths since May 2006.

<span class="mw-page-title-main">Influenza</span> Infectious disease

Influenza, commonly known as the flu, is an infectious disease caused by influenza viruses. Symptoms range from mild to severe and often include fever, runny nose, sore throat, muscle pain, headache, coughing, and fatigue. These symptoms begin one to four days after exposure to the virus and last for about two to eight days. Diarrhea and vomiting can occur, particularly in children. Influenza may progress to pneumonia from the virus or a subsequent bacterial infection. Other complications include acute respiratory distress syndrome, meningitis, encephalitis, and worsening of pre-existing health problems such as asthma and cardiovascular disease.

<span class="mw-page-title-main">2009 swine flu pandemic</span> 2009–2010 pandemic of swine influenza caused by H1N1 influenza virus

The 2009 swine flu pandemic, caused by the H1N1/swine flu/influenza virus and declared by the World Health Organization (WHO) from June 2009 to August 2010, was the third recent flu pandemic involving the H1N1 virus. The first identified human case was in La Gloria, Mexico, a rural town in Veracruz. The virus appeared to be a new strain of H1N1 that resulted from a previous triple reassortment of bird, swine, and human flu viruses which further combined with a Eurasian pig flu virus, leading to the term "swine flu".

The 2009 flu pandemic in the United States was caused by a novel strain of the Influenza A/H1N1 virus, commonly referred to as "swine flu", that was first detected on 15 April 2009. While the 2009 H1N1 virus strain was commonly referred to as "swine flu", there is no evidence that it is endemic to pigs or of transmission from pigs to people; instead, the virus spreads from person to person. On April 25, the World Health Organization declared a public health emergency, followed concurringly by the Obama administration on April 26.

<span class="mw-page-title-main">1976 swine flu outbreak</span> 1976 H1N1 swine influenza outbreak at Fort Dix

In 1976, an outbreak of the swine flu, influenza A virus subtype H1N1 at Fort Dix, New Jersey caused one death, hospitalized 13, and led to a mass immunization program. After the program began, the vaccine was associated with an increase in reports of Guillain–Barré syndrome (GBS), which can cause paralysis, respiratory arrest, and death. The immunization program was ended after approximately 43 million United States citizens had been administered the vaccine.

<span class="mw-page-title-main">Pandemic H1N1/09 virus</span> Virus responsible for the 2009 swine flu pandemic

The pandemic H1N1/09 virus is a swine origin influenza A virus subtype H1N1 strain that was responsible for the 2009 swine flu pandemic. This strain is often called swine flu by the public media due to the prevailing belief that it originated in pigs. The virus is believed to have originated around September 2008 in central Mexico.

Influenza prevention involves taking steps that one can use to decrease their chances of contracting flu viruses, such as the Pandemic H1N1/09 virus, responsible for the 2009 flu pandemic.

The 2009 swine flu pandemic was a global outbreak of a new strain of influenza A virus subtype H1N1, first identified in April 2009, termed Pandemic H1N1/09 virus by the World Health Organization (WHO) and colloquially called swine flu. The outbreak was first observed in Mexico, and quickly spread globally. On the 11th of June 2009, the WHO declared the outbreak to be a pandemic. The overwhelming majority of patients experience mild symptoms, but some persons are at higher risk of suffering more serious effects; such as those with asthma, diabetes, obesity, heart disease, or those who are pregnant or have a weakened immune system. In the rare severe cases, around 3–5 days after symptoms manifest, the sufferer's condition declines quickly, often to the point respiratory failure. Although Ukraine was not (very) affected at first there was on outbreak of the virus in Western Ukraine in early November 2009 that led to the closing of public buildings and cancellation of meetings for three weeks.

<span class="mw-page-title-main">Influenza A virus subtype H7N9</span> Subtype of the influenza A virus

Influenza A virus subtype H7N9 (A/H7N9) is a subtype of the influenza A virus, which causes influenza (flu), predominantly in birds. It is enzootic in many bird populations. The virus can spread rapidly through poultry flocks and among wild birds; it can also infect humans that have been exposed to infected birds.

References

  1. "Case definitions". European Influenza Surveillance Scheme. 12 December 2005. Retrieved 15 July 2009.
  2. "WHO surveillance case definitions for ILI and SARI". WHO. Archived from the original on 19 October 2014. Retrieved 11 March 2020.
  3. "Surveillance Manual". cdc.gov. 29 March 2019. Retrieved 11 March 2020.
  4. 1 2 3 Centers for Disease Control and Prevention (9 November 2001). "Considerations for distinguishing influenza-like illness from inhalational anthrax". Morbidity and Mortality Weekly Report . 50 (44): 984–6. PMID   11724153.
  5. 1 2 "2008–2009 Influenza Season Week 15 ending April 18, 2009". FluView: A Weekly Influenza Surveillance Report Prepared by the Influenza Division. Centers for Disease Control and Prevention. 24 April 2009. Retrieved 26 April 2009.
  6. "Flu Activity & Surveillance". Centers for Disease Control and Prevention. 17 April 2009. Retrieved 26 April 2009.
  7. "Influenza – Frequently asked questions". European Influenza Surveillance Scheme. 21 November 2005. Archived from the original on 10 February 2009. Retrieved 28 April 2009.
  8. Moore C, Corden S, Sinha J, Jones R (November 2008). "Dry cotton or flocked respiratory swabs as a simple collection technique for the molecular detection of respiratory viruses using real-time NASBA". Journal of Virological Methods. 153 (2): 84–9. doi:10.1016/j.jviromet.2008.08.001. PMID   18761378.
  9. Chimenti C, Pieroni M, Frustaci A (April 2006). "Myocarditis: when to suspect and how to diagnose it in athletes". J Cardiovasc Med. 7 (4). Hagerstown: 301–6. doi:10.2459/01.JCM.0000219325.50622.93. PMID   16645406.
  10. Cologna R, Armstrong PM, Rico-Hesse R (January 2005). "Selection for virulent dengue viruses occurs in humans and mosquitoes". J Virol. 79 (2): 853–9. doi:10.1128/JVI.79.2.853-859.2005. PMC   538581 . PMID   15613313.
  11. Moses H, Brandes DW (September 2008). "Managing adverse effects of disease-modifying agents used for treatment of multiple sclerosis". Curr Med Res Opin. 24 (9): 2679–90. doi:10.1185/03007990802329959. PMID   18694542. S2CID   72997113.
  12. Antoniou C, Stefanaki I, Stratigos A, et al. (April 2007). "The Greek experience with efalizumab in psoriasis from a university dermatologic hospital". Br J Dermatol. 156 (Suppl 2): 12–6. doi:10.1111/j.1365-2133.2007.07764.x. PMID   17371318. S2CID   25324493.
  13. Reinisch W, Hommes DW, Van Assche G, et al. (August 2006). "A dose escalating, placebo controlled, double blind, single dose and multidose, safety and tolerability study of fontolizumab, a humanised anti-interferon gamma antibody, in patients with moderate to severe Crohn's disease". Gut. 55 (8): 1138–44. doi:10.1136/gut.2005.079434. PMC   1856289 . PMID   16492717.
  14. Body JJ (August 2001). "Dosing regimens and main adverse events of bisphosphonates". Semin Oncol. 28 (4 Suppl 11): 49–53. doi:10.1016/S0093-7754(01)90232-5. PMID   11544576.
  15. Scheinfeld N, Rosenberg JD, Weinberg JM (2004). "Levamisole in dermatology: a review". Am J Clin Dermatol. 5 (2): 97–104. doi:10.2165/00128071-200405020-00004. PMID   15109274. S2CID   1171779.
  16. Aabenhus, Rune; Jensen, Jens-Ulrik S; Jørgensen, Karsten Juhl; Hróbjartsson, Asbjørn; Bjerrum, Lars (6 November 2014). "Biomarkers as point-of-care tests to guide prescription of antibiotics in patients with acute respiratory infections in primary care". Cochrane Database of Systematic Reviews (11): CD010130. doi:10.1002/14651858.CD010130.pub2. PMID   25374293.
  17. 1 2 Centers for Disease Control and Prevention (26 April 2009). "CDC Health Update: Swine Influenza A (H1N1) Update: New Interim Recommendations and Guidance for Health Directors about Strategic National Stockpile Materiel". Health Alert Network . Retrieved 27 April 2009.
  18. Centers for Disease Control and Prevention (CDC) (2 November 2001). "Update: Investigation of bioterrorism-related anthrax and interim guidelines for clinical evaluation of persons with possible anthrax". Morbidity and Mortality Weekly Report . 50 (43). Centers for Disease Control and Prevention: 941–8. PMID   11708591.
  19. Temte JL, Zinkel AR (September 2004). "The primary care differential diagnosis of inhalational anthrax". Annals of Family Medicine . 2 (5): 438–44. doi:10.1370/afm.125. PMC   1466714 . PMID   15506578.
  20. Waterer GW, Robertson H (January 2009). "Bioterrorism for the respiratory physician". Respirology. 14 (1): 5–11. doi: 10.1111/j.1440-1843.2008.01446.x . PMID   19144044. S2CID   8106844.
  21. Loving, Nancy S (2006). All horse systems go: the horse owner's full-color veterinary care and conditioning resource for modern performance, sport, and pleasure horses. Trafalgar Square Publishing. ISBN   9781570763267. OCLC   61864306. page 439